Updated: January 25, 2026
What Is Ergomar? Uses, Dosage, and What You Need to Know in 2026
Author
Peter Daggett

Summarize with AI
Ergomar is the only sublingual ergotamine tablet in the US for migraine and cluster headache. Here's everything you need to know about it in 2026.
Ergomar is a prescription migraine medication that has been helping patients abort headache attacks for decades. If you've been prescribed it, or if you're researching migraine treatments, this guide covers everything you need to know about what Ergomar is, what it treats, how to take it correctly, and what makes it different from other migraine drugs.
What Is Ergomar?
Ergomar is the brand name for ergotamine tartrate 2 mg sublingual tablets, manufactured by Pangea Pharmaceuticals. It belongs to a class of drugs called ergot alkaloids—derived from a naturally occurring fungus that grows on rye and other grains.
Ergomar is the only sublingual (under-the-tongue) ergotamine product currently available in the United States. It is caffeine-free and aspartame-free, which distinguishes it from older ergotamine-caffeine combination tablets like Cafergot.
What Does Ergomar Treat?
Ergomar is FDA-approved to abort or prevent vascular headaches, specifically:
Migraine headaches (with or without aura)
Migraine variants (including vestibular migraine and ocular migraine)
Cluster headaches (also called histaminic cephalalgia)
Ergomar is an
abortive medication—it is taken when a migraine or cluster attack begins, not as a daily preventive treatment. It will not reduce the frequency of future attacks.
How Is Ergomar Different From Triptans?
Most people have heard of triptans—drugs like sumatriptan (Imitrex) or rizatriptan (Maxalt). Both triptans and ergotamine work to abort migraines, but they differ in important ways:
Duration of action: Ergomar has a longer duration of action than most triptans, which means lower headache recurrence in the 24 hours after treatment. Triptans typically work faster but wear off sooner.
Delivery: Ergomar dissolves under the tongue, bypassing the stomach entirely—an advantage for patients who experience severe nausea during attacks.
Side effect profile: Ergomar has a broader set of contraindications and drug interactions than most triptans. It should not be used in patients with cardiovascular disease, and it has a boxed warning for peripheral ischemia.
Cost: Triptans have generic versions available for $15–$30 per fill. Ergomar is brand-name only with a retail cash price that can exceed $1,600 for 20 tablets—though savings programs can dramatically reduce this cost.
How to Take Ergomar: Correct Dosage and Instructions
Getting the dose right with Ergomar is important both for effectiveness and safety:
Standard dose: 1 tablet (2 mg) placed under the tongue at the first sign of a migraine or cluster headache
Second dose: If needed, a second 2 mg tablet may be taken 30 minutes after the first
Per-attack maximum: No more than 2 tablets for any single attack
Weekly maximum: No more than 5 tablets (10 mg) in any 7-day period
How to take it: Place the tablet under your tongue and let it dissolve completely. Do not crush, chew, or swallow it. Do not eat grapefruit or drink grapefruit juice when using Ergomar.
Timing matters: Ergomar works best when taken at the very first sign of an attack. Waiting until the migraine is severe significantly reduces its effectiveness.
Who Should NOT Take Ergomar?
Ergomar is contraindicated in several important situations:
Pregnancy or breastfeeding (ergotamine stimulates uterine contractions)
Peripheral vascular disease, coronary artery disease, or uncontrolled hypertension
Patients taking potent CYP3A4 inhibitors (clarithromycin, ritonavir, cobicistat, ketoconazole—see boxed warning)
Impaired liver or kidney function
Hypersensitivity to ergotamine or any ergot alkaloid
Is Ergomar a Controlled Substance?
No. Ergomar is not a DEA-scheduled controlled substance. It is a prescription-only medication, but it does not have the same refill restrictions, reporting requirements, or prescribing limitations that apply to controlled substances like stimulants or opioids.
The Bottom Line
Ergomar is a targeted, sublingual migraine and cluster headache abortive with a long history of clinical use. Its longer duration of action makes it especially valuable for patients with high recurrence rates or prolonged attacks. To understand exactly how it works in your body, see: How Does Ergomar Work? Mechanism of Action Explained. If you need help finding it at a pharmacy near you, visit medfinder.
Frequently Asked Questions
Ergomar (ergotamine tartrate 2 mg sublingual tablets) is FDA-approved for the acute treatment and prevention of vascular headaches, including migraine (with or without aura), migraine variants, and cluster headaches. It is an abortive medication taken at the onset of an attack—not a daily preventive.
Both Ergomar and sumatriptan abort migraine attacks, but they work through different mechanisms. Ergomar has a longer duration of action and lower headache recurrence rates than triptans. Sumatriptan typically works faster and is available as an inexpensive generic. Ergomar's sublingual delivery bypasses the stomach, making it useful when nausea is severe.
The maximum dose is 3 tablets (6 mg) in a 24-hour period per GoodRx guidance, though the prescribing information limits each single attack to no more than 2 tablets. No more than 5 tablets (10 mg) may be taken in any 7-day period. Always follow your prescriber's specific instructions.
No. Ergomar is a sublingual tablet designed to dissolve under the tongue. Swallowing it would reduce its effectiveness because oral ergotamine undergoes extensive first-pass metabolism in the liver. Place the tablet under your tongue and let it dissolve completely.
No. Both contain ergotamine tartrate, but Cafergot (ergotamine/caffeine) is a combination product taken orally, while Ergomar is ergotamine-only, caffeine-free, aspartame-free, and taken sublingually (under the tongue). Ergomar's sublingual delivery avoids first-pass metabolism and provides faster absorption for many patients.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Ergomar also looked for:
More about Ergomar
32,900 have already found their meds with Medfinder.
Start your search today.





